Agree. They keep beating forecasts and are in a clear upgrade cycle. CV19 impacts have been a net positive for the business, they’ve successfully embedded acquisitions which reduces operational risk and cash generation is excellent. Wish I got more when they tanked with the market in March. Oh well, will still make good returns here
- Forums
- ASX - By Stock
- UWL
- Ann: Appendix 4C - Quarter ended 31 March 2020
Ann: Appendix 4C - Quarter ended 31 March 2020, page-8
-
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add UWL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, Chief Executive Officer
Paul Long
Chief Executive Officer
SPONSORED BY The Market Online